|
SN-M-LT21
N/A |
|
DSPE-PEG-HAIYPRH (transferrin targeting peptide)
|
￥Member visible
|
|
|
SN-M-LT22
N/A |
|
DSPE-PEG-transferrin targeting peptide
|
￥Member visible
|
|
|
SN-M-LT23
N/A |
|
DSPE-PEG-SP94 (liver cancer targeting peptide)
|
￥Member visible
|
|
|
SN-M-LT24
N/A |
|
DSPE-PEG-OTC (Somatostat receptor targeting peptide)
|
￥Member visible
|
|
|
SN-M-LT25
N/A |
|
DSPE-PEG-TH (PH responsive cell penetrating peptide)
|
￥Member visible
|
|
|
SN-M-LT34
N/A |
|
NGR-mediated tumor neovascularization targeting lipid materials
|
￥Member visible
|
|
|
SN-M-LT35
N/A |
|
APRPG-mediated tumor neovascularization targeting lipid materials
|
￥Member visible
|
|
|
SN-M-LT36
N/A |
|
EGFR targeted lipid material
|
￥Member visible
|
|
|
SN-M-LT37
N/A |
|
PTP-mediated pancreatic cancer targeting lipid materials
|
￥Member visible
|
|
|
SN-M-LT39
N/A |
|
NYZL1 mediates bladder cancer targeting lipid material
|
￥Member visible
|
|
|
SN-M-LT41
N/A |
|
SP94-mediated lipid material targeting liver cancer
|
￥Member visible
|
|
|
SN-M-LT43
N/A |
|
Tumor targeting functional phospholipid material
|
￥Member visible
|
|
|
SN-M-LT30
N/A |
|
DSPE-PEG-SEARYL-PF6 (cell penetrating peptide)
|
￥Member visible
|
|
|
SN-M-LT27
N/A |
|
DSPE-PEG-MPG (cell penetrating peptide)
|
￥Member visible
|
|
|
SN-M-LT28
N/A |
|
DSPE-PEG-SEARYL-R8 (cell penetrating peptide)
|
￥Member visible
|
|
|
SN-M-LT26
N/A |
|
DSPE-PEG-R6H4 (PH responsive cell penetrating peptide)
|
￥Member visible
|
|
|
SN-M-LT19
N/A |
|
DSPE-PEG-FSHB follicle stimulating hormone polypeptide
|
￥Member visible
|
|
|
SN-M-LT18
N/A |
|
DSPE-PEG-PTP（KTLLPTP）
|
￥Member visible
|
|
|
SN-M-LT17
N/A |
|
DSPE-PEG-GE11 (EGFR targeting peptide)
|
￥Member visible
|
|
|
SN-M-LT16
N/A |
|
DSPE-PEG-VIP (vasoactive intestinal peptide)
|
￥Member visible
|
|
|
SN-M-LT14
N/A |
|
DSPE-PEG-NGR (Asn-Gly-Arg) tumor neovascularization targeting peptide
|
￥Member visible
|
|
|
SN-M-LT13
N/A |
|
DSPE-PEG-RGD (Tumor Neovascularization Targeting Peptide)
|
￥Member visible
|
|
|
SN-M-LT12
N/A |
|
DSPE-PEG-cRGD (c[RGDFC]) tumor neovascularization targeting cyclic peptide
|
￥Member visible
|
|
|
SN-M-LT11
N/A |
|
DSPE-PEG-TAT (YGRKKRRQRRR) penetrating peptide
|
￥Member visible
|
|
|
SN-M-LT38
N/A |
|
FSHB-mediated ovarian cancer targeting lipid material
|
￥Member visible
|
|
|
SN-M-LT29
N/A |
|
DSPE-PEG-SEARYL-EB1 (cell penetrating peptide)
|
￥Member visible
|
|
|
SN-M-LT20
N/A |
|
DSPE-PEG-NYZL1（Asn-Tyr-Glx-Leu）
|
￥Member visible
|
|
|
SN-M-LT15
N/A |
|
DSPE-PEG-APRPG (Ala-Pro-Arg-Pro-Gly) tumor neovascularization targeting peptide
|
￥Member visible
|
|
|
SN-M-LT32
N/A |
|
DSPE-PEG-M2pep (M2 type macrophage targeting peptide)
|
￥Member visible
|
|
|
SN-M-LT31
N/A |
|
DSPE-PEG-YSA(YSAYPDSVPMMS)
|
￥Member visible
|
|
|
SN-M-LT33
N/A |
|
DSPE-PEG-ATWLPPR
|
￥Member visible
|
|
|
SN-M-LT40
N/A |
|
DSPE-PEG-F3(KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK)
|
￥Member visible
|
